Filter
208
Filtered Results: 208
Text search:
Barcelona
Institute
for
Global
Health
Featured
Recommendations
12
New Publications
28
Language
Document type
No document type
97
Studies & Reports
57
Guidelines
25
Manuals
16
Strategic & Response Plan
5
Videos
2
Fact sheets
2
Training Material
1
Brochures
1
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
12
Western and Central Europe
11
Brazil
8
Mozambique
5
Ukraine
3
Venezuela
3
Latin America and the Carribbean
3
Paraguay
3
India
3
Colombia
2
Kenya
2
Rwanda
2
Germany
2
West and Central Africa
2
France
2
Ethiopia
2
Nepal
1
Thailand
1
Turkey
1
Cameroon
1
Syria
1
Iran
1
Albania
1
Peru
1
Malawi
1
Morocco
1
Philippines
1
Africa
1
Guinea-Bissau
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
East and Southern Africa
1
Argentina
1
Lebanon
1
Vietnam
1
Uganda
1
Eastern Europe
1
Sudan
1
Greece
1
Georgia
1
Angola
1
Iraq
1
Ecuador
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
35
Clinical Guidelines
24
Public Health
15
Women & Child Health
5
Key Resources
4
Toolboxes
HIV
30
TB
25
Mental Health
18
COVID-19
16
NTDs
15
Planetary Health
12
NCDs
8
AMR
8
Global Health Education
6
Refugee
5
Disability
5
Pharmacy
5
Ebola & Marburg
4
Caregiver
4
Conflict
4
Health Financing Toolbox
2
Polio
2
Rapid Response
1
Natural Hazards
1
Social Ethics
1
Malaria
1
Zika
1
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Good practices in Mental Health and Well-being
PLOS ONE | www.plosone.org
May 2013 | Volume 8 | Issue 5 | e63476
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
Mapping actions of nongovernmental organizations and other international development organizations
Objective: To review research on associations of trauma type with PTSD in the WHO World Mental Health (WMH) surveys, a series of epidemiological surveys that obtained representative data on trauma-specific PTSD.
Mass population movements have accounted for the emergence of Chagas disease (CD) outside endemic regions,
including the European Union/European Economic Area (EU/EEA). The parasite responsible for causing CD,
Trypanosoma cruzi (T. cruzi), can be transmitted through substances of human origin (SoH...
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
The biosphere underlies the whole sustainable development concept, as the layer on
which society and the economy rely. Nature and biodiversity fuel the natural cycles
and life-support systems of the planet, on which humanity ultimately depends.
Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ...
Bled, 26–27 May 2008
Клинический протокол для Европейского региона ВОЗ
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
